
Twist Bioscience Corporation TWST
$ 142.53
1.53%
Country |
|
IPO year |
2018 |
Industry |
Diagnostics research |
Stock Exchange |
NASDAQ GLOBALSPB |
Shares |
59.8 M |
Market Cap[1] |
$ 8.52 B |
EBITDA (LTM) |
$ -111 M |
P/E (LTM) |
-95.938462 |
P/S (LTM) |
19.808307 |
EPS (LTM) |
-1.3 |
Other stocks of industry "Diagnostics research"
| Issuer | Price | % 24h | Market Cap | Exchange | Country | |
|---|---|---|---|---|---|---|
|
Senseonics Holdings
SENS
|
$ 9.02 | 1.81 % | $ 376 M | NYSE American | ||
|
Thermo Fisher Scientific
TMO
|
$ 705.83 | 1.07 % | $ 266 B | NYSE,SPB | ||
|
Agilent Technologies
A
|
$ 177.24 | 1.01 % | $ 50.3 B | NYSE,SPB | ||
|
Anixa Biosciences
ANIX
|
$ 3.27 | 7.04 % | $ 106 K | Nasdaq Capital Market | ||
|
Biodesix
BDSX
|
$ 21.54 | 2.3 % | $ 163 M | Nasdaq Global Market | ||
|
BioNano Genomics
BNGO
|
$ 1.21 | 0.42 % | $ 6.59 M | Nasdaq Capital Market,SPB | ||
|
Bioventus
BVS
|
$ 11.66 | 6.53 % | $ 777 M | Nasdaq Global Select Market | ||
|
Fulgent Genetics
FLGT
|
$ 19.71 | 1.76 % | $ 607 M | Nasdaq Global Market | ||
|
CareDx, Inc
CDNA
|
$ 86.35 | -2.4 % | $ 4.6 B | Nasdaq Global Market,SPB | ||
|
Oxford Immunotec Global PLC
OXFD
|
- | - | $ 562 M | Nasdaq Global Select Market | ||
|
Biomerica
BMRA
|
$ 1.74 | 2.06 % | $ 5.07 M | Nasdaq Capital Market | ||
|
Fluidigm Corporation
FLDM
|
- | 1.08 % | $ 308 M | Nasdaq Global Select Market | ||
|
ICON Public Limited Company
ICLR
|
$ 202.93 | -0.41 % | $ 15.9 B | Nasdaq Global Select Market,SPB | ||
|
IDEXX Laboratories
IDXX
|
$ 699.65 | 4.11 % | $ 56.3 B | Nasdaq Global Select Market,SPB | ||
|
Co-Diagnostics
CODX
|
$ 0.36 | -4.71 % | $ 479 K | Nasdaq Capital Market | ||
|
IQVIA Holdings
IQV
|
$ 266.45 | 1.47 % | $ 45.8 B | NYSE,SPB | ||
|
Burning Rock Biotech Limited
BNR
|
$ 12.77 | 16.73 % | $ 134 M | Nasdaq Global Market | ||
|
PRA Health Sciences, Inc.
PRAH
|
- | - | $ 10.7 B | Nasdaq Global Select Market | ||
|
DarioHealth Corp.
DRIO
|
$ 2.96 | -1.33 % | $ 11.8 M | Nasdaq Capital Market | ||
|
Natera
NTRA
|
$ 390.37 | 0.45 % | $ 53.4 B | Nasdaq Global Select Market,SPB | ||
|
Koninklijke Philips N.V.
PHG
|
$ 31.09 | 9.24 % | $ 29.5 B | NYSE | ||
|
Myriad Genetics
MYGN
|
$ 6.01 | -0.58 % | $ 557 M | Nasdaq Global Select Market,SPB | ||
|
ENDRA Life Sciences
NDRA
|
$ 4.96 | 2.06 % | $ 3.9 M | Nasdaq Global Select Market | ||
|
NeoGenomics
NEO
|
$ 17.11 | 1.66 % | $ 2.19 B | Nasdaq Global Select Market,SPB | ||
|
OPKO Health
OPK
|
$ 1.79 | 4.07 % | $ 1.34 B | Nasdaq Global Select Market | ||
|
Pacific Biosciences of California
PACB
|
$ 2.51 | 2.66 % | $ 753 M | Nasdaq Global Select Market,SPB | ||
|
Neogen Corporation
NEOG
|
$ 12.45 | 2.85 % | $ 2.71 B | Nasdaq Global Select Market,SPB | ||
|
Precipio
PRPO
|
$ 19.64 | 5.48 % | $ 31.5 M | Nasdaq Global Select Market | ||
|
Personalis
PSNL
|
$ 15.8 | 0.29 % | $ 1.41 B | Nasdaq Global Select Market | ||
|
Quidel Corporation
QDEL
|
$ 14.52 | 3.05 % | $ 612 M | Nasdaq Global Select Market,SPB | ||
|
VolitionRx Limited
VNRX
|
$ 0.2 | 5.65 % | $ 25.2 M | NYSE American | ||
|
Centogene N.V.
CNTG
|
- | -6.23 % | $ 30.6 M | Nasdaq Global Market | ||
|
Trinity Biotech plc
TRIB
|
$ 6.43 | -2.02 % | $ 2.31 B | Nasdaq Global Select Market | ||
|
Global Cord Blood Corporation
CO
|
- | - | $ 399 M | NYSE | ||
|
Genetic Technologies Limited
GENE
|
- | - | $ 7.1 B | Nasdaq Capital Market | ||
|
Genetron Holdings Limited
GTH
|
- | 0.12 % | $ 80.1 M | Nasdaq Global Market | ||
|
Aspira Women's Health
AWH
|
- | -6.19 % | $ 10.5 M | Nasdaq Capital Market,SPB | ||
|
Check-Cap Ltd.
CHEK
|
- | - | $ 9.42 M | Nasdaq Capital Market | ||
|
Exact Sciences Corporation
EXAS
|
- | - | $ 19.8 B | Nasdaq Capital Market,SPB | ||
|
National Research Corporation
NRC
|
$ 27.03 | 12.3 % | $ 605 M | Nasdaq Global Select Market | ||
|
Organovo Holdings
ONVO
|
- | -2.3 % | $ 19.4 M | Nasdaq Capital Market | ||
|
OpGen
OPGN
|
- | -16.95 % | $ 1.54 M | Nasdaq Capital Market | ||
|
PerkinElmer
PKI
|
- | -0.91 % | $ 14.7 B | NYSE,SPB | ||
|
Soleno Therapeutics
SLNO
|
- | - | $ 2.69 B | Nasdaq Capital Market | ||
|
Enzo Biochem
ENZ
|
- | -8.98 % | $ 14.8 K | NYSE | ||
|
Guardant Health
GH
|
$ 171.03 | -2.27 % | $ 21.4 B | Nasdaq Global Select Market,SPB | ||
|
Accelerate Diagnostics
AXDX
|
- | -61.36 % | $ 2.46 M | Nasdaq Global Select Market | ||
|
Interpace Biosciences
IDXG
|
$ 5.72 | 5.1 % | $ 25.3 M | Nasdaq Global Select Market | ||
|
Illumina
ILMN
|
$ 226.55 | -4.89 % | $ 35.1 B | Nasdaq Global Select Market,SPB |
References
- Pavone, P. (2019). Market capitalization and financial variables: Evidence from Italian listed companies. International Journal of Academic Research Business and Social Sciences, 9(3), 1356-1371.